4gxs
From Proteopedia
(Difference between revisions)
												
			
			| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Ligand binding domain of GluA2 (AMPA/glutamate receptor) bound to (-)-kaitocephalin==  | ==Ligand binding domain of GluA2 (AMPA/glutamate receptor) bound to (-)-kaitocephalin==  | ||
| - | <StructureSection load='4gxs' size='340' side='right' caption='[[4gxs]], [[Resolution|resolution]] 1.96Å' scene=''>  | + | <StructureSection load='4gxs' size='340' side='right'caption='[[4gxs]], [[Resolution|resolution]] 1.96Å' scene=''>  | 
== Structural highlights ==  | == Structural highlights ==  | ||
| - | <table><tr><td colspan='2'>[[4gxs]] is a 2 chain structure with sequence from [  | + | <table><tr><td colspan='2'>[[4gxs]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GXS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GXS FirstGlance]. <br>  | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0YS:(5R)-2-[(1S,2R)-2-AMINO-2-CARBOXY-1-HYDROXYETHYL]-5-{(2S)-2-CARBOXY-2-[(3,5-DICHLORO-4-HYDROXYBENZOYL)AMINO]ETHYL}-L-PROLINE'>0YS</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>  | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9634Å</td></tr>  | 
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0YS:(5R)-2-[(1S,2R)-2-AMINO-2-CARBOXY-1-HYDROXYETHYL]-5-{(2S)-2-CARBOXY-2-[(3,5-DICHLORO-4-HYDROXYBENZOYL)AMINO]ETHYL}-L-PROLINE'>0YS</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>  | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[  | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gxs FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gxs OCA], [https://pdbe.org/4gxs PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gxs RCSB], [https://www.ebi.ac.uk/pdbsum/4gxs PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gxs ProSAT]</span></td></tr>  | 
</table>  | </table>  | ||
== Function ==  | == Function ==  | ||
| - | [  | + | [https://www.uniprot.org/uniprot/GRIA2_RAT GRIA2_RAT] Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.<ref>PMID:9351977</ref> <ref>PMID:19265014</ref> <ref>PMID:21172611</ref> <ref>PMID:12501192</ref> <ref>PMID:12015593</ref> <ref>PMID:12872125</ref> <ref>PMID:12730367</ref> <ref>PMID:16192394</ref> <ref>PMID:15591246</ref> <ref>PMID:17018279</ref> <ref>PMID:16483599</ref> <ref>PMID:19946266</ref> <ref>PMID:21317873</ref> <ref>PMID:21846932</ref>   | 
<div style="background-color:#fffaf0;">  | <div style="background-color:#fffaf0;">  | ||
== Publication Abstract from PubMed ==  | == Publication Abstract from PubMed ==  | ||
| Line 17: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>  | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>  | ||
</div>  | </div>  | ||
| + | <div class="pdbe-citations 4gxs" style="background-color:#fffaf0;"></div>  | ||
==See Also==  | ==See Also==  | ||
| - | *[[  | + | *[[Glutamate receptor 3D structures|Glutamate receptor 3D structures]]  | 
== References ==  | == References ==  | ||
<references/>  | <references/>  | ||
__TOC__  | __TOC__  | ||
</StructureSection>  | </StructureSection>  | ||
| + | [[Category: Large Structures]]  | ||
[[Category: Rattus norvegicus]]  | [[Category: Rattus norvegicus]]  | ||
| - | [[Category: Ahmed  | + | [[Category: Ahmed AH]]  | 
| - | [[Category: Oswald  | + | [[Category: Oswald RE]]  | 
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Ligand binding domain of GluA2 (AMPA/glutamate receptor) bound to (-)-kaitocephalin
  | |||||||||||
